Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Schultz, S. K. Articles by Andreasen, N. C. Search for Related Content PubMed Citation Articles by Schultz, S. K. Articles by Andreasen, N. C. Neuroendocrinology Schizophrenia Spectrum Disorders

Impaired Glucose Tolerance and Abnormal Movements in Patients With Schizophrenia

OBJECTIVE: Diabetes mellitus has been implicated as a risk factor for tardive dyskinesia. The authors examined the association between abnormal movements and impaired glucose metabolism, which often precedes the development of overt diabetes, in patients with schizophrenia. METHOD: Twenty-one patients with DSM-IV schizophrenia receiving neuroleptic medication were given oral glucose tolerance tests involving serial glucose and insulin levels. These values were analyzed in relationship to abnormal involuntary movement ratings. RESULTS: Patients with impaired glucose tolerance had higher mean abnormal movement scores than those without glucose intolerance, but this difference was not statistically significant. There was, however, an association between the magnitude of the fasting insulin level and abnormal movements after the authors controlled for fasting glucose level. Additionally, the fasting glucose level predicted abnormal movements after the authors controlled for age. CONCLUSIONS: Hyperinsulinemia and hyperglycemia associated with insulin resistance may potentially contribute to the pathogenesis of tardive dyskinesia. Findings from this small cross-sectional study suggest a possible relationship that requires clarification through larger, longitudinal studies.

This article has been cited by other articles:

				C. P. Carney and L. E. Jones Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med, September 1, 2006; 68(5): 684 - 691. [Abstract] [Full Text] [PDF]

				J. L. Reay, D. O. Kennedy, and A. B. Scholey Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity J Psychopharmacol, July 1, 2005; 19(4): 357 - 365. [Abstract] [PDF]

				M. C.M. Ryan, P. Collins, and J. H. Thakore Impaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With Schizophrenia Am J Psychiatry, February 1, 2003; 160(2): 284 - 289. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 1999 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us